American Stock Exchange Lists SPARQS Linked to Biogen Idec Inc.

American Stock Exchange Lists SPARQS Linked to Biogen Idec Inc.



NEW YORK, Sept. 24  /PRNewswire/ -- The American Stock Exchange(R) (Amex(R))
today began trading Morgan Stanley 7% Stock Participation Accreting Redemption
Quarterly-pay Securities ("SPARQS") mandatorily exchangeable for shares of
common stock of Biogen Idec Inc.  Trading under the ticker symbol BIS, the
1.854 million units of the new securities were issued at $5.931 with a maturity
date of November 1, 2005.

At maturity, holders will receive one tenth of one share of Biogen Idec, Inc.
common stock in exchange for each SPARQS, subject to the issuer's right to call
the SPARQS for the cash call price.

The issuer is Morgan Stanley and the Amex specialist unit for the new listing
is AIM Securities/Aegis Joint Account.

If you would like to receive a copy of the prospectus for BIS, please contact
the Capital Markets Group at the American Stock Exchange at (212) 306- 1659.

The American Stock Exchange(R) (Amex(R)) is the only primary exchange that
offers trading across a full range of equities, options and exchange traded
funds (ETFs), including structured products and HOLDRS(SM).  In addition to its
role as a national equities market, the Amex is the pioneer of the ETF,
responsible for bringing the first domestic product to market in 1993. Leading
the industry in ETF listings, the Amex lists 139 ETFs.  The Amex is also one of
the largest options exchanges in the U.S., trading options on broad-based and
sector indexes as well as domestic and foreign stocks.  For more information,
please visit http://www.amex.com/. 

DATASOURCE: The American Stock Exchange



CONTACT: Media, Lynn Duffy, American Stock Exchange, [phone], or





Web site:  http://www.amex.com/ 

Copyright